Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

GNOM 3.14
price chart
Mountain View's Complete Genomics sheds jobs, changes mission
Mountain View-based Complete Genomics Inc. is laying off 179 Bay Area workers as part of a strategy shift by its Chinese parent company, BGI, according to a state layoff notice and company statement.
BGI-Shenzhen Agrees to Buy Complete Genomics
Complete Genomics's sequencing technology gives results slower than that of Illumina Inc., BGI's major supplier of sequencing machines, said George Church, who advises both Complete Genomics and BGI. However, studies have shown that the technology ...
BGI-Shenzhen to acquire Complete Genomics for $117M  Bizjournals.com
Complete Genomics Announces UK Epilepsy Society's Acquisition of Its ...
MOUNTAIN VIEW, Calif., Oct. 6, 2015 /PRNewswire/ -- Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company's newly introduced ...
Epilepsy Society becomes third customer of Complete Genomics' newly ...  News-Medical.net
Illumina, Complete Genomics Settle Patent Disputes
Law360, Los Angeles (July 18, 2013, 8:04 PM ET) -- Complete Genomics Inc. and Illumina Inc. have agreed to settle all claims in two separate patent infringement cases brought by Illumina over four of its patents, without payment being made by either ...
Related articles »  
Complete Genomics: A Leader In DNA Sequencing
Complete Genomics (NASDAQ:GNOM) was founded in 2005 and is headquartered in Mountain View, CA. It is an up and coming life sciences company that develops and commercializes an innovative DNA sequencing platform for complete human genome ...
Complete Genomics rejects Illumina bid over Chinese acquirer
Complete Genomics Inc. rejected a $123.5 million acquisition bid from Illumina Inc., a victory for potential buyer BGI-Shenzhen of China.
Complete Genomics: Say No To The Sale - Part 2
It's tragic that Complete Genomics (NASDAQ:GNOM) is being sold for a price that you would put on to expired aspirin. Among all the chatter that has surrounded the company subsequent to the buyout announcement, no one has said that $3.15 is a fair price.
Complete Genomics CEO on DNA Sequencing Capacity
January 30, 2012 12:50 AM EST - Jan. 30 (Bloomberg) -- Clifford Reid, chief executive officer of Complete Genomics Inc., talks about the company's genome sequencing technology and capacity outlook.
Photo Release -- Complete Genomics Appoints Ethan Knowlden as Senior Vice ...
MOUNTAIN VIEW, Calif., Sept. 17, 2013 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), a wholly-owned subsidiary of BGI-Shenzhen, a leading international genomics organization based in Shenzhen, China, ...
Related articles »  
BGI-Shenzhen Acquires US-Based Complete Genomics For $117M
19, 2013) - BGI, a genomics company based in Shenzhen, China, has successfully acquired U.S.-based whole human genomic sequencing provider, Complete Genomics, Inc., through its wholly-owned subsidiary, Beta Acquisition Corporation. BGI completed ...
Related articles »